INS and type 2 diabetes mellitus: Appendix Table S5: The Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non‐insulin Antidiabetic Therapy (EDITION 3 trial) with 878 patients was a multicenter study carried out in North America, Europe, and Japan,25, 26 and another RCT with 604 patients met our preplanned study section criteria conducted in China.27